Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Journal of Neuroendocrinology|February 17, 2022
Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasmsRodrigo Taboada, Laura Claro, Tiago Felismino, et al.Endocrine Oncology (Bristol, England)|November 14, 2024
Less frequent radiological exams to avoid futile response assessments from 177-LuDOTATE therapy for patients with advanced neuroendocrine tumorsCarolina C Marques, Angelo B Brito, Eduardo N Lima, et al.Cancer|July 14, 2007
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancerRachel P Riechelmann, Carol A Townsley, Sheray N Chin, et al.Journal of Pain and Symptom Management|April 2, 2011
Adverse drug reactions and drug interactions as causes of hospital admission in oncologyVanessa Miranda, Angelo Fede, Melissa Nobuo, et al.Revista Da Associacao Medica Brasileira (1992)|February 23, 2017
A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamineJuliana Florinda M Rêgo, Gilberto Lopes, Rachel P Riechelmann, et al.Therapeutic Advances in Medical Oncology|March 14, 2020
Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancerVictor H F de Jesus, Marcos P G Camandaroba, Vinicius F Calsavara, et al.Cancers|November 27, 2024
The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine TumorsRodrigo G Taboada, Angelo B Brito, Ana Luiza Silva, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 31, 2023
Therapy Sequencing in Patients With Advanced Neuroendocrine NeoplasmsRachel P Riechelmann, Rodrigo G Taboada, Victor Hugo F de Jesus, et al.Therapeutic Advances in Medical Oncology|May 19, 2026
Neoadjuvant therapy versus upfront surgery followed by adjuvant chemotherapy in resectable or borderline resectable PDAC: a systematic review and meta-analysis of RCTsVictor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Álvaro Lopes de Oliveira, et al.Clinical Colorectal Cancer|January 9, 2017
Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch RepairAlexandra Khichfy Alex, Sheila Siqueira, Renata Coudry, et al.Pageof 10